GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » PB Ratio

ANL (Adlai Nortye) PB Ratio : 1.38 (As of Oct. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-10-31), Adlai Nortye's share price is $2.00. Adlai Nortye's Book Value per Share for the quarter that ended in Jun. 2024 was $1.45. Hence, Adlai Nortye's PB Ratio of today is 1.38.

The historical rank and industry rank for Adlai Nortye's PB Ratio or its related term are showing as below:

ANL' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 6.88
Current: 1.41

During the past 3 years, Adlai Nortye's highest PB Ratio was 6.88. The lowest was 0.00. And the median was 0.00.

ANL's PB Ratio is ranked better than
71.32% of 1269 companies
in the Biotechnology industry
Industry Median: 2.49 vs ANL: 1.41

Back to Basics: PB Ratio


Adlai Nortye PB Ratio Historical Data

The historical data trend for Adlai Nortye's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye PB Ratio Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 4.18

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial - - - 4.18 2.25

Competitive Comparison of Adlai Nortye's PB Ratio

For the Biotechnology subindustry, Adlai Nortye's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adlai Nortye's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's PB Ratio distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's PB Ratio falls into.



Adlai Nortye PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Adlai Nortye's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=2.00/1.446
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Adlai Nortye  (NAS:ANL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Adlai Nortye PB Ratio Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Adlai Nortye Business Description

Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.